Related Experiment Video
Updated: Mar 27, 2026

Isolation of Functional Cardiac Immune Cells
Published on: December 5, 2011
Cardiovascular symptoms in patients with systemic mast cell activation disease
Ulrich W Kolck1, Britta Haenisch2, Gerhard J Molderings3
1Johanniter-Kliniken Bonn, Waldkrankenhaus, Innere Medizin II, Bonn, Germany.
Abstract:
Traditionally, mast cell activation disease (MCAD) has been considered as just one rare (neoplastic) disease, mastocytosis, focused on the mast cell (MC) mediators tryptase and histamine and the suggestive, blatant symptoms of flushing and anaphylaxis. Recently another form of MCAD, the MC activation syndrome, has been recognized featuring inappropriate MC activation with little to no neoplasia and likely much more heterogeneously clonal and far more prevalent than mastocytosis. Increasing expertise and appreciation has been established for the truly very large menagerie of MC mediators and their complex patterns of release, engendering complex, nebulous presentations of chronic and acute illness best characterized as multisystem polymorbidity of generally inflammatory ± allergic theme. We describe the pathogenesis of MCAD with a particular focus on clinical cardiovascular symptoms and the therapeutic options for MC mediator-induced cardiovascular symptoms.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Heart Failure III: Clinical Manifestations
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...

